Geneos Wealth Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$24K 2122
2022
Q3
$24K Sell
100
-500
-83% -$135K ﹤0.01% 1269
2022
Q2
$152K Hold
600
0.01% 849
2022
Q1
$198K Buy
600
+100
+20% +$30.8K 0.01% 811
2021
Q4
$179K Hold
500
0.01% 918
2021
Q3
$161K Hold
500
0.01% 955
2021
Q2
$158K Hold
500
0.01% 957
2021
Q1
$160K Hold
500
﹤0.01% 1072
2020
Q4
$150K Sell
500
-10
-2% -$2.77K 0.01% 952
2020
Q3
$135K Buy
510
+10
+2% +$2.88K 0.01% 821
2020
Q2
$119K Hold
500
0.01% 841
2020
Q1
$72K Hold
500
﹤0.01% 967
2019
Q4
$84K Sell
500
-100
-17% -$18.5K ﹤0.01% 1020
2019
Q3
$105K Hold
600
0.01% 876
2019
Q2
$156K Sell
600
-11
-2% -$2.92K 0.01% 752
2019
Q1
$174K Hold
611
0.01% 692
2018
Q4
$194K Buy
611
+11
+2% +$3.82K 0.01% 613
2018
Q3
$269K Hold
600
0.02% 542
2018
Q2
$245K Hold
600
0.02% 517
2018
Q1
$174K Hold
600
0.02% 575
2017
Q4
$112K Buy
600
+100
+20% +$18.7K 0.01% 710
2017
Q3
$84K Hold
500
0.01% 758
2017
Q2
$71K Sell
500
-12
-2% -$1.61K 0.01% 801
2017
Q1
$64K Sell
512
-10
-2% -$1.16K 0.01% 806
2016
Q4
$58K Buy
522
+250
+92% +$29K 0.01% 788
2016
Q3
$34K Buy
272
+22
+9% +$2.63K ﹤0.01% 946
2016
Q2
$27K Hold
250
﹤0.01% 1026
2016
Q1
$24K Buy
+250
New +$21.1K ﹤0.01% 1036

Other funds holding ABMD

Geneos Wealth Management's ABMD Position: Q4 2022 in Review

Geneos Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 100 shares — an estimated $24K sold.

Geneos Wealth Management first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $269K in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Geneos Wealth Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 100 Abiomed Inc shares in Q4 2022, an estimated $24K.
  • Geneos Wealth Management first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
  • Geneos Wealth Management's Abiomed Inc position peaked at $269K in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.